SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-009566
Filing Date
2017-02-10
Accepted
2017-02-10 16:41:08
Documents
1
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 SUBMISSION doc5.html 5  
1 FORM 5 SUBMISSION doc5.xml 5 8878
  Complete submission text file 0001209191-17-009566.txt   10458
Mailing Address 2601 FOURTH AVENUE SUITE 500 SEATTLE WA 98121
Business Address 2601 FOURTH AVENUE SUITE 500 SEATTLE WA 98121 (206) 801-2100
Cascadian Therapeutics, Inc. (Issuer) CIK: 0001412067 (see all company filings)

IRS No.: 260868560 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 110 110TH AVENUE NE SUITE 685 BELLEVUE WA 98004
Business Address
Jackson Richard L. (Reporting) CIK: 0001418872 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-33882 | Film No.: 17594082